Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy

In patients suspected of having PVC-CM, IC-AADs effectively suppressed PVCs, leading to LVEF recovery in the majority. No adverse events occurred in this small cohort.